Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Walsh

Showing results (251-260 of 361) with videos related to

Pageof 37
Sort By:
Urology|January 18, 2006
Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostateMark L Gonzalgo, Patrick J Bastian, Leslie A Mangold, et al.
Regional Anesthesia and Pain Medicine|December 6, 2005
Correlation of postoperative pain to quality of recovery in the immediate postoperative periodChristopher L Wu, Andrew J Rowlingson, Alan W Partin, et al.
BJU International|March 18, 2008
Progression after radical prostatectomy for men in their thirties compared to older menStacy Loeb, David J Hernandez, Leslie A Mangold, et al.
The Journal of Urology|July 4, 2006
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/mlDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
Urology|June 19, 2007
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Danil V Makarov, Bruce J Trock, Elizabeth B Humphreys, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostateRobert W Veltri, Masood A Khan, M Craig Miller, et al.
BJU International|February 1, 2012
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancerAshley E Ross, Zhaoyong Feng, Phillip M Pierorazio, et al.
BJU International|April 17, 2012
Prostate-specific antigen concentration in young men: new estimates and review of the literatureSiobhan Sutcliffe, Ratna Pakpahan, Lori J Sokoll, et al.
The Journal of Urology|May 7, 2013
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillanceJeffrey J Tosoian, Eric JohnBull, Bruce J Trock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Active surveillance program for prostate cancer: an update of the Johns Hopkins experienceJeffrey J Tosoian, Bruce J Trock, Patricia Landis, et al.
Pageof 37

Showing results (251-260 of 361) with videos related to

Sort By:
Pageof 37
Urology|January 18, 2006
Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostateMark L Gonzalgo, Patrick J Bastian, Leslie A Mangold, et al.
Regional Anesthesia and Pain Medicine|December 6, 2005
Correlation of postoperative pain to quality of recovery in the immediate postoperative periodChristopher L Wu, Andrew J Rowlingson, Alan W Partin, et al.
BJU International|March 18, 2008
Progression after radical prostatectomy for men in their thirties compared to older menStacy Loeb, David J Hernandez, Leslie A Mangold, et al.
The Journal of Urology|July 4, 2006
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/mlDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
Urology|June 19, 2007
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Danil V Makarov, Bruce J Trock, Elizabeth B Humphreys, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostateRobert W Veltri, Masood A Khan, M Craig Miller, et al.
BJU International|February 1, 2012
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancerAshley E Ross, Zhaoyong Feng, Phillip M Pierorazio, et al.
BJU International|April 17, 2012
Prostate-specific antigen concentration in young men: new estimates and review of the literatureSiobhan Sutcliffe, Ratna Pakpahan, Lori J Sokoll, et al.
The Journal of Urology|May 7, 2013
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillanceJeffrey J Tosoian, Eric JohnBull, Bruce J Trock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Active surveillance program for prostate cancer: an update of the Johns Hopkins experienceJeffrey J Tosoian, Bruce J Trock, Patricia Landis, et al.
Pageof 37